Dr. Tachiki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Education & Training
University of California, Irvine, School of MedicineClass of 2016
Certifications & Licensure
WA State Medical License 2016 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses.Thomas Pulliam, Saumya Jani, Peter H Goff, Rashmi Bhakuni, Shira Tabachnick-Cherny
Journal for Immunotherapy of Cancer. 2024-10-14 - Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes.Rian Alam, Xinyi Fan, Daniel S Hippe, Lisa M Tachiki, Emily Gong
Cancers. 2024-07-07 - The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze
Cancer. 2024-06-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
